Articles

The Ratings Game: Disney’s ‘lifeblood’ is under pressure. These analysts see a few possible fixes.

Walt Disney Co.'s story has a lot of moving parts these days, but perhaps none more critical than problems with the company's "lifeblood."

Cannabis Watch: Cannabis company TerrAscend draws kudos from analysts with Toronto Stock Exchange listing on tap for next week

Cannabis company with U.S. operations set to begin trading Tuesday on the TSX in a move seen as potentially attracting more support from investors.

: Supreme Court ruling on student debt will ‘devastate’ millions of borrowers. No, it would have ‘punished’ poor Americans. Who’s right?

Biden estimated that student-loan forgiveness would have helped more than 40 million borrowers. Republicans disagree.

Economic Report: U.S. economy on track to grow as fast as 2% in the second quarter

The U.S. economy expanded at a surprisingly robust 2% pace in the first three months of the year --- and it could mimic that performance in the second quarter.

: Do Not Disturb: Tenants brace for more office landlords to go belly up on their property debts

U.S. office tenants increasingly want leases that provide protections against landlords who default, which can throw a property into foreclosure.

: Failed Russian mutiny presents ‘window of opportunity’ for Ukraine NATO accession, says top Zelensky adviser

The Ukrainian government is looking forward to next month's NATO summit as an opportunity for the U.S. and its allies solidify their commitment to Ukraine

Market Extra: Japanese stocks see best first-half in a decade. Here’s what it will take for the rally to continue.

Japanese stocks just clinched their best first-half performance since the dawn of "Abenomics" in 2012, but some doubt whether Japanese stocks can continue to outperform U.S. and European stocks during the second half of this year.

The Margin: What is aspartame, and is it bad for you? Here’s what health experts say.

The World Health Organization may declare aspartame a cancer-causing agent, reports say. Here’s what you need to know about the common sugar substitute.

: For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say 

Lower-price biosimilar competition for top-selling drug launching this weekend. 

: Biden to announce next steps on student loans after Supreme Court rejects forgiveness plan

President Biden will announce what the White House is calling next steps to protect student-loan borrowers, after the Supreme Court blocked his plan.

IPO Report: Like shoppers, IPO investors are demanding discounts and showing price sensitivity

IPO investors, much like shoppers in the current inflationary environment, are demanding discounts, according to Renaissance Capital.

: AMC shares fall, while APE units rise as stock-conversion battle reaches Delaware Chancery Court

A key hearing in AMC’s push to convert APE units into common stock started Thursday at Delaware Chancery Court.
1 1,730 1,731 1,732 1,733 1,734 1,821